BiotechTube
Home/Pipeline/Carboplatin LNP Formulation

Carboplatin LNP Formulation

Cancer

PreclinicalActive

Key Facts

Indication
Cancer
Phase
Preclinical
Status
Active
Company
Adeira Pharma

About Adeira Pharma

Adeira Pharma is a private, preclinical biotech leveraging a versatile targeted nanoparticle platform to overcome historical drug formulation challenges. Its core technology enables the encapsulation or surface attachment of diverse therapeutic payloads, aiming to enhance pharmacokinetics, reduce toxicity, and improve targeted delivery. The company is currently seeking development partners for its lead reformulation candidates, primarily in oncology, and operates a partnership-focused business model without disclosed revenue.

View full company profile

Therapeutic Areas

Oncology

Other Cancer Drugs

DrugCompanyPhase
Not Specified (Oncology Focus)Narwhal BioPre-clinical
EDM Platform for Genetic MedicineCoastar TherapeuticsPre-clinical
CO-1Caedo OncologyPre-clinical
Anti-CD99 monoclonal antibodyCaedo OncologyDiscovery/Pre-clinical
Anti-HLA class I monoclonal antibodyCaedo OncologyDiscovery/Pre-clinical
Triapine®NanopharmaceuticsClinical
Ammonium TetrathiomolybdateNanopharmaceuticsClinical
Aza-TdCNanopharmaceuticsClinical
Undisclosed Oncology Program(s)Cell BioEnginesPhase 1
No-alpha IL-2 MuteinSarcoMed USAPre-clinical
PMIS TherapeuticNaturemiRIPreclinical/Clinical (unspecified)
AUM302 (formerly IBL-302)Inflection BiosciencesPre-clinical (partnered)